SearcharxivSearch

arXiv subjects

Slava V Rotkin

Publications and source records attributed to Slava V Rotkin.

2 recordsLinked to original sources

Defect Engineered 2D MoS2 Materials for ML-enabled Neurotransmitter SERS Detection

An attachment of catechol-containing neurotransmitter molecules is demonstrated on defect-engineered two-dimensional MoS2 platform, leading to activation of SERS due to molecular charge transfer. Mechanisms of neurotransmitters' bio-detection are discussed and Machine Learning methods are applied to distinguish spectra of structurally similar analytes. The SERS effect and selective docking of biomolecules are achieved through an optimized approach for defect engineering: namely, introducing the sulfur vacancies in MoS2 monolayer films via soft plasma etching led to molecular attachment driven by catechol functional groups. The quality of the sensor material was controlled by Raman, photoluminescence, and XPS characterization, thus allowing for optimization of the process of defect formation and achieving sensing selectivity. The sensor material showed no response to serotonin, confirming the specificity of attachment/SERS due to S-vacancies that regulate the strength of catechol-specific molecular adsorption. Defect-engineered MoS2 has enabled SERS detection of dopamine and epinephrine down to the sub-nanomolar range ($5\times10^{-10}$ M), with strong calibration reliability ($R^2$ = 0.95 and 0.99 for pure samples). PCA-LDA achieved 100$\%$ accuracy in distinguishing dopamine and epinephrine, which establishes defect-engineered MoS2 as a tunable, low-cost SERS platform for future sensing applications.

cond-mat.mes-hall

Heterointerface-Engineered Electrochemically Exfoliated MoS2/WS2 2D-Layered Nanocomposite for Efficient Visible-Light Photocatalytic Degradation of Sorafenib

The increasing prevalence of pharmaceutical contaminants within the aquatic environment has generated considerable environmental concerns, especially regarding persistent anticancer medications like the kinase inhibitor sorafenib (SRF), which are inadequately eliminated by standard degradation methods. A heterointerface-engineered MoS2/WS2, 2D/2D layered nanocomposite was fabricated using an electrochemical exfoliation method to facilitate effective visible-light-driven photocatalytic degradation of SRF. The electrochemical exfoliation method yielded ultrathin 9.62-layer thickness MoS2/WS2 nanosheets with numerous exposed edge sites and an increased specific surface area, facilitating the development of well-interconnected van der Waals heterointerfaces. Comprehensive structural and morphological examinations utilizing field emission scanning electron microscopy (FE-SEM), atomic force microscopy (AFM), Raman spectroscopy, and UV-visible spectroscopy validated the effective synthesis of few-layer nanosheets and their heterostructure interfaces. In contrast to the pure MoS2 and WS2 nanosheets, the MoS2/WS2 heterostructure composite demonstrated significantly enhanced photocatalytic efficacy, attaining roughly 92 % degradation of SRF within 2h under visible-light exposure. The enhanced catalytic efficiency is mainly due to the establishment of a Type-II band alignment at the MoS2/WS2 interface, facilitating effective charge separation and directional charge transfer while inhibiting electron-hole recombination. The robust interfacial interaction among the transition metal dichalcogenide layers accelerates visible-light absorption and the production of reactive oxygen species. This study illustrates that electrochemically exfoliated MoS2/WS2 heterostructure composites serve as a viable catalytic platform for the successful removal of persistent pharmaceutical pollutants.

cond-mat.mtrl-sci